Stockscreener 앱 받기
4.7199
0.43%
0.0299
전일 마감가:
$4.69
열려 있는:
$4.71
하루 거래량:
28,909
Relative Volume:
0.04
시가총액:
$35.42M
수익:
$14.58M
순이익/손실:
$-12.57M
주가수익비율:
-0.831
EPS:
-5.68
순현금흐름:
$-13.07M
1주 성능:
+14.04%
1개월 성능:
-10.11%
6개월 성능:
+38.94%
1년 성능:
+68.21%
1일 변동 폭
$4.61
$4.8214
1주일 범위
$4.0201
$5.12
52주 변동 폭
$1.98
$7.95
비보스 테라퓨틱스 Stock (VVOS) Company Profile
명칭
Vivos Therapeutics Inc
전화
(866)908-4867
주소
7921 SOUTHPARK PLAZA,, LITTLETON
VVOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
4.7199 | 27.24M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
131.41 | 229.51B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.38 | 155.75B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
391.82 | 149.44B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.02 | 117.93B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.40 | 47.47B | 5.69B | 1.41B | 577.90M | 6.95 |
비보스 테라퓨틱스 주식(VVOS)의 최신 뉴스
Published on: 2025-08-27 04:31:19 - Newser
Reversal indicators forming on Vivos Therapeutics Inc. stock2025 Fundamental Recap & Reliable Price Breakout Alerts - Newser
Published on: 2025-08-27 03:13:04 - Newser
News impact scoring models applied to Vivos Therapeutics Inc.July 2025 Short Interest & Short-Term High Return Strategies - Newser
Can Vivos Therapeutics Inc. hit a new high this monthRisk Management & Weekly Chart Analysis and Trade Guides - Newser
What the charts say about Vivos Therapeutics Inc. today2025 Trading Recap & Growth Oriented Trade Recommendations - Newser
What to expect from Vivos Therapeutics Inc. in the next 30 daysPortfolio Value Summary & Consistent Income Trade Recommendations - Newser
Market reaction to Vivos Therapeutics Inc.’s recent newsJuly 2025 Sentiment & Weekly Breakout Stock Alerts - Newser
Earnings visualization tools for Vivos Therapeutics Inc.2025 Historical Comparison & Risk Managed Trade Strategies - Newser
What data driven models say about Vivos Therapeutics Inc.’s futureJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Candlestick Reversal Detected on Vivos Therapeutics Inc.’s Chart getLinesFromResByArray error: size == 0 - metrotimes.co.kr
Visualizing Vivos Therapeutics Inc. stock with heatmaps2025 Price Targets & Safe Entry Trade Signal Reports - Newser
Custom strategy builders for tracking Vivos Therapeutics Inc.2025 Biggest Moves & Precise Buy Zone Identification - Newser
Tick level data insight on Vivos Therapeutics Inc. volatilityWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Applying sector rotation models to Vivos Therapeutics Inc.Weekly Gains Summary & Long-Term Capital Growth Ideas - Newser
Published on: 2025-08-25 20:41:17 - Newser
Measuring Vivos Therapeutics Inc.’s beta against major indicesPortfolio Return Report & Accurate Buy Signal Notifications - Newser
Should you hold or exit Vivos Therapeutics Inc. now2025 Market Sentiment & AI Driven Stock Movement Reports - Newser
Vivos Therapeutics, Inc: From Strategic Pivot to Business Model Pivot - Smartkarma
Statistical indicators supporting Vivos Therapeutics Inc.’s strengthInsider Buying & Weekly Stock Performance Updates - Newser
Will Vivos Therapeutics Inc. benefit from AI trends2025 Trade Ideas & Safe Capital Growth Stock Tips - theviewers.co.kr
Will Vivos Therapeutics Inc. stock go up in YEARRate Cut & AI Optimized Trade Strategies - sundaytimes.kr
What candlestick patterns are forming on Vivos Therapeutics Inc.2025 Trading Recap & Real-Time Chart Pattern Alerts - Newser
Is Vivos Therapeutics Inc. stock bottoming outJuly 2025 Patterns & Daily Profit Maximizing Tips - Newser
Moving Average Crossover Confirms Uptrend in Vivos Therapeutics Inc.July 2025 Movers & Risk Adjusted Buy and Sell Alerts - beatles.ru
Vivos Therapeutics Q2 2025 Earnings Call Highlights Growth and Expansion Plans - AInvest
Vivos Therapeutics shares fall 1.96% after-hours as Gilead Sciences acquires Interius BioTherapeutics for $350 million. - AInvest
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q2 2025 Earnings Call Transcript - Insider Monkey
Understanding Vivos Therapeutics Inc.’s price movement2025 Market Trends & High Accuracy Swing Entry Alerts - Newser
Vivos Therapeutics Inc Reports Q2 2025 Revenue of $3.8M, Slightly Exceeding Estimates; EPS Misses at -$0.55 - AInvest
Vivos Therapeutics' Strategic Pivot: Can the Sleep Optimization Model Redefine OSA Treatment Leadership? - AInvest
Vivos Reports 7% Sales Drop - The Motley Fool
Vivos Reports 7% Sales Drop - Nasdaq
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update - TradingView
Vivos Therapeutics Q2 FY25: Revenue up 25%, Acquires Sleep Center of Nevada - AInvest
Vivos Therapeutics Inc. Stock Approaches Key Moving Average2025 Macro Impact & AI Based Trade Execution Alerts - newsyoung.net
Biotech Sector Resilience and Vivos Therapeutics: A High-Risk, High-Reward Proposition? - AInvest
Vivos Therapeutics Announces Q2 2025 Financial Results Release and Conference Call - AInvest
Vivos Therapeutics Reports Q2 2025 Earnings: Revenue Challenges and Strategic Growth - AInvest
Recovery Signals Appearing in Vivos Therapeutics Inc. Charts2025 Stock Rankings & Stepwise Trade Signal Guides - beatles.ru
Vivos Therapeutics shares fall 3.75% premarket after reporting Q2 2025 earnings and acquisition of The Sleep Center of Nevada. - AInvest
Is Vivos Therapeutics Inc. reversing from oversold territoryMarket Sentiment Report & AI Forecast for Swing Trade Picks - Newser
Vivos Therapeutics Unveils New Model - AOL.com
Vivos Therapeutics Shifts Strategy Amid Financial Challenges - TipRanks
Transcript : Vivos Therapeutics, Inc., Q2 2025 Earnings Call, Aug 19, 2025 - MarketScreener
비보스 테라퓨틱스 (VVOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.50%
자본화:
|
볼륨(24시간):